On January 13-14, 2026, the "Empowerment Service Conference · Dabo Forum (Heilongjiang, Jilin, Liaoning) Summit" organized by the Pharmaceutical Circulation Professional Committee of the China Non-prescription Medicines Association kicked off in Changchun. Changchun Renmin Pharmaceutical Group, as a representative of local pharmaceutical enterprises, participated in the industry event, showcasing its strength through booth P26. Not only did it demonstrate the capabilities of its core products, but it also won the "Strategic Cooperation Enterprise Award," delivering an impressive performance amid the wave of innovation in pharmaceutical retail.
The Dabo Forum, themed "Jointly Shaping a New Landscape for Pharmaceutical Retail Growth," brought together industry experts, brand pharmaceutical companies, and elites from northeastern chain pharmacies to focus on hot topics such as policy interpretation, category upgrading, and digital operations.
Changchun Renmin Pharmaceutical Group showcased over 10 series of traditional Chinese patent medicines, including those for colds/respiratory systems, rheumatism and bone injuries, and tonic supplements, at booth P26. Rooted in ancient formulas and methods, and upgraded through modern pharmaceutical technology innovations, the display attracted numerous attendees to stop by and inquire. The on-site exchange buzz continued to rise, with many procurement managers from chain pharmacies expressing cooperation intentions on the spot, laying a solid foundation for subsequent channel expansion.
During the forum, Changchun Renmin Pharmaceutical Group was awarded the "Strategic Cooperation Enterprise Award" for its long-term in-depth engagement and collaborative contributions in the pharmaceutical retail sector. This honor not only represents industry recognition of the company's brand influence but also highlights its proactive role in promoting the co-construction of the regional pharmaceutical retail ecosystem.
